MedDataX Logo

Trimodal Prehabilitation in Patients Undergoing Elective Surgery

NCT ID: NCT05114408

Last Updated: 2021-11-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-06-07

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients scheduled for elective surgery will undergo 4 week course of trimodal prehabilitation

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with high surgical risk will participate in 4 week prehabilitation that will consist of 4 stationary sessions - one per week - comprised of: physiotherapy session, psychological session and nutritional advice. During first session each patient will receive an activity monitor and dedicated mobile app that will record his daily performance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Complication Perioperative Complication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Trimodal prehabilitation

Patients qualified for elective surgery that meet criteria for prehabilitation

Group Type EXPERIMENTAL

4 week trimodal prehabilitation course

Intervention Type OTHER

trimodal prehabilitation in mixed: stationary and "at-home" structure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

4 week trimodal prehabilitation course

trimodal prehabilitation in mixed: stationary and "at-home" structure

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 70 and/or American Society of American Society of Anesthesiologists Physical Status Classification System (ASA) 3-4
* Unfit patients

Exclusion Criteria

* physical condition that makes the patient is not able to perform rehabilitation exercises
* cardiac and respiratory instability or high risk of its occurrence
* inability to use electronic devices used in the study
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Clinical Centre, Gdansk

OTHER

Sponsor Role collaborator

EIT Health

OTHER

Sponsor Role collaborator

Medical University of Gdansk

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Clinical Center in Gdansk - Departament of Anesthesiolog and Intensive cCre

Gdansk, , Poland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Poland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tomasz Jasiński, MD PhD

Role: CONTACT

Phone: +48583493280

Email: [email protected]

Mateusz Kreczko, MD

Role: CONTACT

Phone: +48583493280

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tomasz Jasinski, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PREHAB1

Identifier Type: -

Identifier Source: org_study_id